As a member of ONO Group, Deciphera is a biopharmaceutical company focused on discovering, developing, and commercializing important new medicines to improve the lives of people with cancer. We are leveraging our proprietary switch-control kinase inhibitor platform and deep expertise in kinase biology to develop a broad portfolio of innovative medicines. For more information, visit www.deciphera.com.
Looking for a particular Deciphera Pharmaceuticals employee's phone or email?
The Deciphera Pharmaceuticals annual revenue was $174.9 million in 2026.
Ryota Udagawa is the President and Chief Executive Officer of Deciphera Pharmaceuticals.
428 people are employed at Deciphera Pharmaceuticals.
Deciphera Pharmaceuticals is based in Waltham, Massachusetts.
The NAICS codes for Deciphera Pharmaceuticals are [325, 32541, 32, 3254, 325413].
The SIC codes for Deciphera Pharmaceuticals are [283, 873, 87, 28].